Drug intelligence / Profile preview

Zebinuron

Development stage
Unknown
Lead developer
Resilient Cosmeceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Zebinuron is a neurotropic supplement combination developed by Resilient Cosmeceuticals, primarily indicated for the management of diabetic neuropathy, alcoholic neuropathy, and drug-induced neuropathy. The formulation typically consists of a fixed-dose combination of methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride (Vitamin B6), and folic acid (Vitamin B9). Methylcobalamin, a bioactive form of Vitamin B12, is essential for the synthesis of the myelin sheath and promotes nerve regeneration. Alpha-lipoic acid serves as a potent antioxidant that reduces oxidative stress and improves nerve conduction velocity and blood flow to peripheral nerves. Pyridoxine and folic acid act as vital cofactors in neurotransmitter synthesis and cellular metabolic processes, collectively supporting the repair and maintenance of the nervous system.

Brand names
Zebinuron
Other names
Zebinuron Capsule
02

Targets

MTR (Methionine synthase)DDC (Aromatic L-amino acid decarboxylase)PDH (Pyruvate dehydrogenase complex)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on Zebinuron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zebinuron.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call